STOCK-BASED COMPENSATION - RSAs (formerly PIUs), RSUs, RSUs - Founder’s Award, Employee Warrants and Earnouts (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restricted stock awards
SARs
Outstanding, beginning (in shares)	2,808,978
Granted prior to/after the Reverse Recapitalization (in shares)	0	0
Vested prior to/after the Reverse Recapitalization (in shares)	(1,167,014)
Forfeited prior to/after the Reverse Recapitalization (in shares)	(775,857)
Outstanding, ending (in shares)	866,107	2,808,978
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 1.01
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)	0		$ 0.83
Exercised prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)	1.36
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)	1.20
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 1.64	$ 1.01
Restricted stock units
SARs
Outstanding, beginning (in shares)	8,859,207
Granted prior to/after the Reverse Recapitalization (in shares)	16,050,035		0
Vested prior to/after the Reverse Recapitalization (in shares)	(5,456,486)		0
Forfeited prior to/after the Reverse Recapitalization (in shares)	(4,770,163)
Outstanding, ending (in shares)	14,682,593	8,859,207
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 5.71
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)	2.71	$ 5.71
Vested prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)	4.14
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)	3.86
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 3.60	$ 5.71
Restricted stock units - founder’s award
SARs
Outstanding, beginning (in shares)	9,258,298
Granted prior to/after the Reverse Recapitalization (in shares)	0
Vested prior to/after the Reverse Recapitalization (in shares)	0
Forfeited prior to/after the Reverse Recapitalization (in shares)	0
Outstanding, ending (in shares)	9,258,298	9,258,298
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 5.06
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)	0	$ 5.06
Vested prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)	0
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)	0
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 5.06	$ 5.06
Employee Warrants
SARs
Outstanding, beginning (in shares)	188,958
Granted prior to/after the Reverse Recapitalization (in shares)	0
Exercised prior to/after the Reverse Recapitalization (in shares)	0
Forfeited prior to/after the Reverse Recapitalization (in shares)	0
Expired prior to/after the Reverse Recapitalization (in shares)	0
Outstanding, ending (in shares)	188,958	188,958
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 11.50
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)	0
Exercised prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)	0
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)	0
Expired prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)	0
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 11.50	$ 11.50
Outstanding, Weighted-Average Remaining Contractual Terms in Years	3 years 8 months 19 days
Outstanding, Aggregate Intrinsic Value	$ 0
Employee Earnouts
SARs
Outstanding, beginning (in shares)	309,179
Granted prior to/after the Reverse Recapitalization (in shares)	0
Vested prior to/after the Reverse Recapitalization (in shares)	0
Forfeited prior to/after the Reverse Recapitalization (in shares)	0
Outstanding, ending (in shares)	309,179	309,179
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Outstanding, beginning, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 8.94
Granted prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)	0
Vested prior to/after the Reverse Recapitalization, Weighted-Average Grant Date Fair Value Per Share (in dollars per share)	0
Forfeited prior to/after the Reverse Recapitalization, Weighted-Average Exercise Price Per Share (in dollars per share)	0
Outstanding, ending, Weighted-Average Exercise Price Per Share (in dollars per share)	$ 8.94	$ 8.94